公司資料
LadRx 股價、新聞與催化劑
- 股票代碼:
- LADX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.01 USD (0.00%)
收盤價
最後更新: 2026年6月22日
—
市值
股價為何變動
Current closing-price context is not available for LADX.
公司概覽
業務概覽
LadRx was a biotechnology company historically focused on oncology and drug delivery before becoming a legacy ticker. Its story centered on the challenge of turning a narrow therapeutic concept into durable value.
所在地與產業分類
LadRx was headquartered in the United States and traded on NASDAQ. It sat in small-cap oncology and drug-delivery biotechnology.
商業模式特徵
The company depended on clinical progress, strategic changes, and capital support while advancing a narrow pipeline. Investors historically watched proof-of-concept and financing runway.
生技產業定位
LadRx is best understood as a historical small-cap oncology biotech name. Like many micro-cap drug developers, its stock was driven by pipeline risk and capital needs.
未來催化劑
- LadRx is now a legacy / closeout story, so the catalysts are any residual strategic or asset-resolution update. The market is focused on what value remains.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。